Organic compounds -- part of the class 532-570 series – Organic compounds – Heavy metal containing
Reexamination Certificate
2011-07-12
2011-07-12
Gonzalez, Porfirio Nazario (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heavy metal containing
C514S492000, C548S108000, C548S304100
Reexamination Certificate
active
07977500
ABSTRACT:
The subject invention concerns biotin-conjugated platinum complexes that exhibit direct and indirect (immunological) antitumor cell activity. The subject invention also concerns the biotin-platinum complexes of the invention that have another molecule, such as an antibody, a ligand, a receptor, etc., bound to the biotin moiety. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.
REFERENCES:
patent: 3904663 (1975-09-01), Tobe et al.
patent: 4177263 (1979-12-01), Rosenberg et al.
patent: 5648384 (1997-07-01), Kidani et al.
patent: 5714327 (1998-02-01), Houthoff et al.
patent: 5849790 (1998-12-01), Palmer et al.
patent: 5902826 (1999-05-01), Mogi et al.
patent: 5998648 (1999-12-01), Sohn et al.
patent: 6503943 (2003-01-01), Zak et al.
patent: 7128893 (2006-10-01), Leamon et al.
patent: 7166733 (2007-01-01), Nowotnik et al.
patent: 7238372 (2007-07-01), Turkson et al.
patent: 7566798 (2009-07-01), Kay et al.
patent: 7754684 (2010-07-01), Stewart et al.
patent: 7759510 (2010-07-01), Kay et al.
patent: 7763585 (2010-07-01), Turkson et al.
patent: 2004/0175387 (2004-09-01), Sood et al.
patent: 2005/0220754 (2005-10-01), Russell-Jones et al.
patent: 2005/0288365 (2005-12-01), Kay et al.
patent: 2006/0127310 (2006-06-01), Russell-Jones et al.
patent: H08-176175 (1996-07-01), None
patent: WO 96/26949 (1996-09-01), None
patent: WO 2005/016946 (2005-02-01), None
patent: WO 2005/023824 (2005-03-01), None
Kortepeter et al., Emerging Infectious Diseases, vol. 14, No. 6, pp. 881-887 (2008).
Heetebrij, R. J. et al., “Platinum (II)-Based Coordination Compounds as Nucleic Acid Labeling Reagents: Synthesis, Reactivity, and Applications in Hybridization Assays”Chem Bio Chem, 2003, pp. 573-583, vol. 4.
Cleare, M.J. and Hoeschele, J.D. “Anti-tumour platinum compounds. Relationship between structure and activity”Platinum Metals Rev., 1973, 17(1):2-13.
Samatov et al. Izvestiya Akademii Nauk SSSR Seriya Khimicheskaya, 1974, pp. 1467-1472, No. 9.
Chernyaev et al. Zhurnal Neorganicheskoi Khimii, 1966, pp. 1365-1373, vol. 11.
Muraveiskaya et al. Zhurnal Neorganicheskoi Khimii, 1971, pp. 1643-1649, vol. 16.
Rudyi et al. Koordinatsionnaya Khimiya, 1975, p. 1572. vol. 1.
Muravenskaya et al. Koordinatsionnaya Khimiya, 1975, pp. 779-790. vol. 1.
Le Postollec “Spectres de vibration et struture de composes de coordination nitres du platine IV”Journal de La Chimie Physique et de Physico-Chime Biologique, 1965, pp, 67-72, vol. 62.
Samatov et al. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1974, pp. 2142-2144.
Chernyaev, I.I. et al. “Nitrosation of amines in platinum (IV) triamines of ribbed structure”Zhumal Neorganicheskol Khimil, 1967, pp. 1877-1885, vol. 12, No. 7.
Adrianova, O.N. et al. “Anomaly of the acid properties of platinum cis-dinitrotriamines of meridonal structure”Zhurnal Neorganicheskoi Khimii, 1978, pp. 2155-2158, vol. 23, No. 8.
Howell, B.A. et at. “Substituted catecholato(1,2-diaminocyclohexane) platinum(II) compounds”lnorganica Chimica Acta, 1988, pp. 181-183, vol. 142, No. 2.
Bromberg, J. “Stat proteins and oncogenesis”J. Clin. Invest., 2002, pp. 1139-1142, vol. 109.
Leamon, C.P. et al. “Folate-mediated targeting: from diagnostics to drug and gene delivery”DDT, Jan. 2001, pp. 44-51, vol. 6, No. 1.
Lu, Y. et al. “Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential”Advanced Drug Delivery Reviews, 2004, pp. 1161-1176, vol. 56.
Russel-Jones, G. et at. “Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours”Journal of Inorganic Biochemistry, pp. 1625-1633, vol. 98, (2004).
Schechter, B. et al. “Polymers in drug delivery: Immunotargeting of carrier-supportedcis-platinum complexes”Reactive Polymers, pp. 167-175, vol. 25. (1995).
Walker, R. et al. “Biotinylation facilitates the uptake of large peptides byescherichia coliand other gram-negative bacteria”Applied and Environmental Microbiology, Apr. 2005, pp. 1850-1855, vol. 71, No. 4.
Gonzalez Porfirio Nazario
Saliwanchik Lloyd & Eisenschenk
University of South Florida
LandOfFree
Platinum complexes for targeted drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platinum complexes for targeted drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platinum complexes for targeted drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619818